Study to test how effective a cream is to reduce dark spots

Effectiveness of a combination of anti-pigmentary products in management of facial post-inflammatory hyperpigmentation - ECAPMFP

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009932

Enrollment

114

Registered

2017-09-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Post-inflammatory pigmentation

Interventions

Intervention1: Combination of anti-pigmentary products: Cream containing arbutin, licorice extract, pTerowhite 90%, niacinamide Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to give informed consent. Patients willing to take the medication as directed and comply with the study protocol. Patient willing to use sunscreen

Exclusion criteria

Exclusion criteria: Patients with lichen planus pigmentosus. Patients unwilling or unable to comply with the study protocol.

Design outcomes

Primary

Measure	Time frame
Number of hyperpigmentation patches. Average size of hyperpigmentation patch.Post inflammatory hyperpigmentation severity scale. Photographic assessment.Timepoint: Day 8, 15, 29, 85	—

Secondary

Measure	Time frame
Absence of any side-effectsTimepoint: Day 8,15,29, 85	—

Countries

India

Contacts

Public ContactChitra Shivanand Nayak

BYL Nair Ch Hospital & TNMC

chitra212@hotmail.com9819107591

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026